Dymphy Huntjens

Dymphy Huntjens has extensive work experience in the field of clinical pharmacology and pharmacometrics. Dymphy is currently serving as the Head of Clinical Pharmacology and Pharmacometrics at Priothera SAS since March 2022. Prior to this, they held the position of Scientific Director at The Janssen Pharmaceutical Companies of Johnson & Johnson from April 2021 to March 2022.

Dymphy also worked at Johnson & Johnson for a significant period, starting in 2007. Dymphy'sroles included Clinical Pharmacology Regional Head, Associate Scientific Director, Associate Director of Systems Pharmacology, and Senior Scientist. Dymphy'stenure at Johnson & Johnson lasted from January 2012 to March 2022.

Before joining Johnson & Johnson, Dymphy worked as a Modeling and Simulation Expert at Grunenthal GmbH from November 2005 to June 2007. Dymphy also served as a PhD student at LACDR from September 2001 to November 2005 and at GlaxoSmithKline from 2001 to 2005.

Dymphy Huntjens completed their Doctor of Philosophy (PhD) in Pharmacology from Leiden University between 2001 and 2008. Prior to that, they obtained their Master of Science (MS) in Bio pharmaceutical sciences from Universiteit Leiden from 1997 to 2001.